Validation of the Self-Assessment of Treatment Questionnaire among Patients with Postherpetic Neuralgia

Table 5

Descriptive statistics for SAT items at Week 12 (pooled dataset; 𝑁=698)¹.

SAT item	N	Mean (SD)	Median	Floor (n, %)	Ceiling (n, %)
(1) How do you assess your pain relief after treatment in this study?	698	0.6 (0.9)	0	8 (1.1%)	154 (22.1%)
(2) How do you assess your activity level after treatment in this study?	698	0.4 (0.8)	0	8 (1.1%)	86 (12.3%)
(3) How has your quality of life changed after treatment in this study?	698	0.5 (0.8)	0	6 (0.9%)	114 (16.3%)
(4) Would you undergo this treatment again?	698	1.0 (1.2)	2	41 (5.9%)	356 (51.0%)
(5) How do you compare the treatment you received in this study to previous medication or therapies for your pain?	698	0.5 (1.1)	0	39 (5.6%)	179 (25.6%)

SAT: Self-Assessment of Treatment; SD: standard deviation.
¹Pooled dataset included data from two clinical trials, Studies C116 (𝑁=349) and C117 (𝑁=349).